Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep;24(9):1218-1220.
doi: 10.1111/1756-185X.14202. Epub 2021 Aug 6.

Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection

Chokan Baimukhamedov  1
Affiliations
Case Reports

Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection

Chokan Baimukhamedov. Int J Rheum Dis. 2021 Sep.
No abstract available

Keywords: SARS-CoV-2 infection; SPUTNIK-V; arthritis; vaccination against SARS-CoV-2 infection.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Arthritis of the left elbow joint
FIGURE 2
FIGURE 2
Ultrasonography of the left elbow joint revealing moderate effusion in the left elbow fossa
FIGURE 3
FIGURE 3
Magnetic resonance imaging showing elbow joint arthritis
See this image and copyright information in PMC

References

    1. Won JH, Lee H. The current status of drug repositioning and vaccine developments for the COVID‐19 pandemic. Int J Mol Sci. 2020;21:9775. doi: 10.3390/ijms21249775 - DOI - PMC - PubMed
    1. Baimukhamedov C, Barskova T, Matucci‐Cerinic M. Arthritis after SARS‐CoV‐2 infection. Lancet Rheumatol. 2021;3:e324‐e325. doi: 10.1016/S2665-9913(21)00067-9 - DOI - PMC - PubMed
    1. Terracina KA, Tan FK. Flare of rheumatoid arthritis after COVID‐19 vaccination. Lancet Rheumatol. 2021;3:e469‐e470. doi: 10.1016/S2665-9913(21)00108 - DOI - PMC - PubMed
    1. Boekel L, Kummer LY, van Dam KPJ, et al. Adverse events after first COVID‐19 vaccination in patients with autoimmune diseases. Lancet Rheumatol. 2021;3(8):e542‐e545. doi: 10.1016/S2665-9913(21)00181-8 - DOI - PMC - PubMed

Substances